JP2022523712A5 - - Google Patents
Info
- Publication number
- JP2022523712A5 JP2022523712A5 JP2021544181A JP2021544181A JP2022523712A5 JP 2022523712 A5 JP2022523712 A5 JP 2022523712A5 JP 2021544181 A JP2021544181 A JP 2021544181A JP 2021544181 A JP2021544181 A JP 2021544181A JP 2022523712 A5 JP2022523712 A5 JP 2022523712A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798012P | 2019-01-29 | 2019-01-29 | |
| US62/798,012 | 2019-01-29 | ||
| PCT/US2020/015002 WO2020159824A1 (en) | 2019-01-29 | 2020-01-24 | Therapeutic compounds and compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523712A JP2022523712A (ja) | 2022-04-26 |
| JP2022523712A5 true JP2022523712A5 (https=) | 2023-01-20 |
| JPWO2020159824A5 JPWO2020159824A5 (https=) | 2023-01-20 |
Family
ID=71841895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544181A Pending JP2022523712A (ja) | 2019-01-29 | 2020-01-24 | 治療用化合物および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210361634A1 (https=) |
| EP (1) | EP3917910A4 (https=) |
| JP (1) | JP2022523712A (https=) |
| KR (1) | KR20210119432A (https=) |
| CN (1) | CN113784951A (https=) |
| AU (1) | AU2020216887A1 (https=) |
| BR (1) | BR112021014956A2 (https=) |
| CA (1) | CA3128018A1 (https=) |
| IL (1) | IL285167A (https=) |
| WO (1) | WO2020159824A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2733405C2 (ru) | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| EP3749662A4 (en) | 2018-02-07 | 2021-07-14 | Exithera Pharmaceuticals Inc. | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
| KR20210084581A (ko) * | 2018-10-30 | 2021-07-07 | 엑시테라 파마슈티컬스 인코퍼레이티드 | 치료 화합물 및 조성물 |
| TW202345825A (zh) * | 2022-03-30 | 2023-12-01 | 大陸商四川海思科製藥有限公司 | 環狀內醯胺類化合物的注射用藥物組合物及其製備方法 |
| CN117723658A (zh) * | 2023-12-08 | 2024-03-19 | 山东齐都药业有限公司 | Hplc法测定丁苯酞氯化钠注射液中羟丙基倍他环糊精的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003321364A (ja) * | 2002-05-07 | 2003-11-11 | Eisai Co Ltd | シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物 |
| US20060128654A1 (en) * | 2004-12-10 | 2006-06-15 | Chunlin Tang | Pharmaceutical formulation of cytidine analogs and derivatives |
| CA2648522A1 (en) * | 2005-04-04 | 2006-10-12 | Daiamed, Inc. | Substituted azetidinones |
| CN103415301A (zh) * | 2011-03-09 | 2013-11-27 | 德国杰特贝林生物制品有限公司 | 用于与包括与人造表面接触的医疗操作一起施用的fxii抑制剂 |
| RU2733405C2 (ru) * | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| US20190315711A1 (en) * | 2016-12-23 | 2019-10-17 | Exithera Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
-
2020
- 2020-01-24 EP EP20748002.1A patent/EP3917910A4/en not_active Withdrawn
- 2020-01-24 KR KR1020217025742A patent/KR20210119432A/ko not_active Withdrawn
- 2020-01-24 AU AU2020216887A patent/AU2020216887A1/en not_active Abandoned
- 2020-01-24 CA CA3128018A patent/CA3128018A1/en active Pending
- 2020-01-24 BR BR112021014956-2A patent/BR112021014956A2/pt not_active Application Discontinuation
- 2020-01-24 JP JP2021544181A patent/JP2022523712A/ja active Pending
- 2020-01-24 CN CN202080019754.5A patent/CN113784951A/zh active Pending
- 2020-01-24 WO PCT/US2020/015002 patent/WO2020159824A1/en not_active Ceased
-
2021
- 2021-07-27 IL IL285167A patent/IL285167A/en unknown
- 2021-07-29 US US17/388,859 patent/US20210361634A1/en not_active Abandoned
-
2023
- 2023-04-19 US US18/136,734 patent/US20230270731A1/en not_active Abandoned